Procurement Summary
Country: Kazakhstan
Summary: Medicines for Jsc Research Institute Kvb, Amt: 3004043.00
Deadline: 21 Sep 2026
Posting Date: 22 Sep 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 149570188
Document Ref. No.: 17645470-1
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: KZT 3004043.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Lots: Warfarin 2.5 mg No. 100 | Tofisopam tablet 50 mg No. 20 | Rivaroxaban tablet 15 mg No. 28 | Lornoxicam lyophilisate for solution 8 mg 10 ml No. 5 | Furosemide solution for injection 1% - 2 ml No. 10 ampoule | Valsartan, film-coated tablets, 80 mg, No. 30 | Rivaroxaban tablet 20 mg No. 28 | Cyanocobalamin, pyridoxine hydrochloride, thiamine hydrochloride - Milgamma solution for injection 2 ml, No. 5 ampoule | Thiotriazolin - Thiazotic acid solution for intravenous administration 50 mg/4 ml No. 10 ampoule | Moxonidine 0.4 mg, No. 14 | Isosorbide dinitrate, concentrate for the preparation of solution for infusion 1 mg/ml 10 ml No. 5 | Succinic acid, inosine, nicotinamide, riboflavin (in mononucleotide form) - Inosine+Nicotinamide+riboflavin+succinic acid solution for injection 10 ml No. 10 | Valsartan, film-coated tablets, 160 mg, No. 30 | Vinpocetine solution for injection 5 mg/ml 2 ml No. 10 ampoule | Ascorbic acid - Ascorbic acid, solution for injection, 5%, 2 ml, No. 10 ampoule | Human blood coagulation factor IX 500 IU - Phosphrucutose powder for preparation of solution 5.0 No. 1 FDP
Documents
Tender Notice